
| NAME | DATE | TM | OPP | MIN | PTS | REB | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  |  T. Maxey   | 1/20/2021    |  PHI | vs    |  BOS | 21    | 0    | 2    | 2    | 0    | 0    | 0    | 4    | 0.0    | 0    | 1    | 0.0    | 0    | 0    | 0.0    | 0    | 2    | 0    | 2    | +2    | |
| 2 |  |  T. Maxey   | 1/22/2021    |  PHI | vs    |  BOS | 6    | 2    | 3    | 0    | 0    | 0    | 1    | 1    | 100.0    | 0    | 0    | 0    | 0    | 100.0    | 0    | 3    | 0    | 0    | +1    | ||
| 3 |  |  T. Maxey   | 1/14/2022    |  PHI | vs    |  BOS | 38    | 23    | 0    | 5    | 1    | 0    | 8    | 16    | 50.0    | 5    | 7    | 71.4    | 2    | 2    | 100.0    | 68.1    | 0    | 0    | 0    | 2    | +6    | 
| 4 |  |  T. Maxey   | 2/15/2022    |  PHI | vs    |  BOS | 31    | 11    | 2    | 1    | 0    | 0    | 3    | 11    | 27.3    | 1    | 4    | 25.0    | 4    | 4    | 100.0    | 43.1    | 0    | 2    | 1    | 1    | -34    | 
| 5 |  |  T. Maxey   | 2/25/2023    |  PHI | vs    |  BOS | 25    | 8    | 2    | 2    | 1    | 0    | 4    | 10    | 40.0    | 0    | 2    | 0.0    | 0    | 0    | 40.0    | 0    | 2    | 0    | 2    | -11    | |
| 6 |  |  T. Maxey   | 4/4/2023    |  PHI | vs    |  BOS | 40    | 5    | 4    | 1    | 0    | 1    | 2    | 8    | 25.0    | 1    | 4    | 25.0    | 0    | 0    | 31.3    | 0    | 4    | 4    | 5    | +17    | |
| 7 |  |  T. Maxey   | 11/8/2023    |  PHI | vs    |  BOS | 39    | 25    | 9    | 5    | 1    | 2    | 11    | 27    | 40.7    | 3    | 11    | 27.3    | 0    | 1    | 0.0    | 45.6    | 1    | 8    | 1    | 4    | -3    | 
| 8 |  |  T. Maxey   | 11/15/2023    |  PHI | vs    |  BOS | 39    | 20    | 3    | 4    | 0    | 0    | 6    | 15    | 40.0    | 3    | 7    | 42.9    | 5    | 5    | 100.0    | 58.1    | 0    | 3    | 2    | 3    | +9    | 
| 9 |  |  T. Maxey   | 2/2/2025    |  PHI | vs    |  BOS | 40    | 34    | 3    | 6    | 0    | 0    | 9    | 21    | 42.9    | 5    | 8    | 62.5    | 11    | 11    | 100.0    | 65.8    | 0    | 3    | 2    | 4    | 0    | 
| 10 |  |  T. Maxey   | 2/20/2025    |  PHI | vs    |  BOS | 34    | 16    | 5    | 7    | 1    | 0    | 6    | 10    | 60.0    | 1    | 4    | 25.0    | 3    | 3    | 100.0    | 70.7    | 0    | 5    | 0    | 2    | -25    | 
| Average | 31.3 | 14.4 | 3.3 | 3.3 | 0.4 | 0.3 | 5.0 | 12.3 | 40.7 | 1.9 | 4.8 | 39.6 | 2.5 | 2.6 | 96.2 | 53.6 | 0.1 | 3.2 | 1.0 | 2.5 | -3.8 | ||||||
| Total | 313 | 144 | 33 | 33 | 4 | 3 | 50 | 123 | 40.7 | 19 | 48 | 39.6 | 25 | 26 | 96.2 | 53.6 | 1 | 32 | 10 | 25 | -38 | 
ORTG
125.5
3rd
DRTG
120.2
24th
NETRTG
5.3
10th
3P%
41.9
1st